Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)
Clinical trial NCT07556120 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07556120
- Sponsor
- Shenzhen MagicRNA Biotechnology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-12-31
- Primary completion
- 2027-05-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.